John Cuozzo

John Cuozzo is an accomplished leader in drug discovery with extensive experience across various biotech and pharmaceutical companies. Currently serving as SVP and Head of Drug Discovery at VantAI, John previously held the position of VP of Discovery Technologies at Relay Therapeutics, where significant advancements in machine learning applications for drug discovery were achieved. At ZebiAI Therapeutics, John facilitated a successful acquisition by Relay Therapeutics, while previous roles at X-Chem and Syndexa Pharmaceuticals underscored expertise in building teams and driving innovative drug discovery strategies. With a robust academic background, including a PhD in Cellular and Molecular Physiology from Tufts University School of Medicine, John has contributed to multiple therapeutic areas and established successful collaborations with leading institutions.